BDBM37552 6-(1-benzofuran-2-yl)-3-[(3,4-dimethoxyphenyl)methyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine::6-(2-benzofuranyl)-3-[(3,4-dimethoxyphenyl)methyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine::6-(benzofuran-2-yl)-3-veratryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine::MLS000057323::SMR000063641::cid_2998319

SMILES COc1ccc(Cc2nnc3SCC(=Nn23)c2cc3ccccc3o2)cc1OC

InChI Key InChIKey=WCTGQIUSCIRCFM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 37552   

TargetHuntingtin(Homo sapiens (Human))
Columbia University Molecular Screening Center

Curated by PubChem BioAssay
LigandPNGBDBM37552(6-(1-benzofuran-2-yl)-3-[(3,4-dimethoxyphenyl)meth...)
Affinity DataIC50: >8.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair
In DepthDetails PCBioAssay